Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma

Auris Nasus Larynx

Volumn 34, Issue 4, 2007, Pages 493-498

  Kim, Hyun Jik ^a   Kim, Chang Hoon ^b   Lee, Bong Jae ^c   Chung, Yoo Sam ^c   Kim, Jin Kook ^d   Choi, Yoon Seok ^e   Yoon, Joo Heon ^b  

^a Chung Ang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e Inha University School of Medicine   (South Korea)

Author keywords

Concurrent chemoradiotherapy; Craniofacial resection; Olfactory neuroblastoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE NECROSIS; BRAIN ABSCESS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CEREBROSPINAL FLUID FISTULA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPISTAXIS; ESTHESIONEUROBLASTOMA; FEMALE; HUMAN; MALE; MENINGITIS; NEUTROPENIA; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASAL CAVITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOSE NEOPLASMS; RADIOTHERAPY DOSAGE; RETREATMENT; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 35349030723     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.02.005     Document Type: Article

References (19)

1. Berger L., and Luc R. L'esthesioneuroepitheliome olfactif. Bull Assoc Franc Etude Cancer 13 (1924) 410-421
2. Diaz E.M., Johnigan R.H., Pero C., El-Naggar A.K., Roberts D.B., Barker J.L., et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 27 (2005) 138-149
3. Levine P.A., McLean W.C., and Cantrell R.W. Esthesioneuroblastoma: the University of Virginia experience 1960-1985. Laryngoscope 96 (1986) 742-746
4. Constantinidis J., Steinhart H., Koch M., Buchfelder M., Schaenzer A., Weidenbecher M., et al. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000. Otolaryngol Head Neck Surg 130 (2004) 567-574
5. Dulguerov P., and Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 102 (1992) 843-849
6. Sakata K., Aoki Y., Karasawa K., Nakagawa K., Hasezawa K., Muta N., et al. Esthesioneuroblastoma. A report of seven cases. Acta Oncol 32 (1993) 399-402
7. McElroy E.A., Buckner J.C., and Lewis J.E. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 42 (1998) 1023-1028
8. Morita A., Ebersold M.J., Olsen K.D., Foote R.L., Lewis J.E., and Quast L.M. Esthesioneuroblastoma: prognosis and management. Neurosurgery 32 (1993) 706-715
9. Levine P.A., Gallagher R., and Cantrell R.W. Estheioneuroblastoma: reflections of a 21-year experience. Laryngoscope 109 (1999) 1539-1543
10. Eriksen J.G., Bastholt L., Krogdahl A.S., Hansen O., and Joergensen K.E. Esthesioneuroblastoma. What is the optimal treatment?. Acta Oncol 39 (2000) 231-235
11. Koka V.N., Julieron M., Bourhis J., Janot F., Le Ridant A.M., Marandas P., et al. Aesthesioneuroblastoma. J Laryngol Otol 112 (1998) 628-633
12. Dulguerov P., and Calcaterra T. Esthesioneuroblastoma: UCLA experience 1970-1990. Laryngoscope 102 (1992) 843-850
13. Resto V.A., Eisele D.W., Forastiere A., Zahurak M., Lee D.J., and Westra W.H. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 55 (2000) 550-558
14. Walch C., Stammberger H., Anderhuber W., Unger F., Kole W., and Feichtinger K. The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 110 (2000) 635-640
15. Foote R.L., Morita A., Ebersold M.J., Olsen K.D., Lewis J.E., Quast L.M., et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 27 (1993) 835-842
16. Polonowski J.M., Brasnu D., Roux F.X., and Bassot V. Esthesioneuroblastoma: complete tumor response after induction chemotherapy. Ear Nose Throat J 69 (1990) 743-746
17. Kim D.W., Jo Y.H., Heo D.S., Wu H.G., Rhee C.S., Lee C.H., et al. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 101 (2004) 2257-2260
18. Eden B.V., Debo R.F., Larner J.M., Kelly M.D., Levine P.A., Stewart F.M., et al. Esthesioneuroblastoma. Cancer 73 (1994) 2556-2562
19. Wade P.M., Smith R.E., and Johns M.E. Response of esthesioneuroblastoma to chemotherapy: report of five cases and review of the literature. Cancer 53 (1984) 1036-1041